10.2 Cardiac Stress Protocols & Vascular Anatomy

10.2 Cardiac Stress Protocols & Vascular Anatomy

Quick Answer: Cardiac stress testing induces hyperemia to uncover flow-limiting coronary artery stenoses. Physical exercise stress targets $\ge 85\%$ Maximum Predicted Heart Rate (MPHR). Pharmacologic stress utilizes coronary vasodilators (regadenoson, adenosine, dipyridamole) or inotropic/chronotropic stimulation (dobutamine). Knowledge of caffeine contraindications, aminophylline reversal, and 17-segment coronary vascular territories (LAD, RCA, LCX) is essential for board mastery.

Under resting conditions, baseline myocardial blood flow remains normal even in coronary arteries with up to $70-80\%$ luminal diameter narrowing, owing to compensatory autoregulatory vasodilation of downstream resistance arterioles. Cardiac stress testing exhausts this autoregulatory reserve, creating a flow discrepancy between normal myocardium (where blood flow increases 3- to 5-fold) and ischemic myocardium (where flow fails to increase proportionally).

Exercise Stress Testing Protocols

Symptom-limited treadmill exercise is the physiological gold standard for patients capable of exertion. It provides incremental diagnostic data including functional exercise capacity (in METs), blood pressure kinetics, heart rate recovery, and exercise-induced ST-segment shifts.

The Standard Bruce Protocol

Increases treadmill speed and elevation gradient every 3 minutes:

• Stage 1: $1.7\ \text{mph}$ at $10\%$ grade ($4.8\ \text{METs}$)
• Stage 2: $2.5\ \text{mph}$ at $12\%$ grade ($7.0\ \text{METs}$)
• Stage 3: $3.4\ \text{mph}$ at $14\%$ grade ($10.1\ \text{METs}$)

Target Heart Rate (THR) & Double Product

• Maximum Predicted Heart Rate (MPHR): $\text{MPHR} = 220 - \text{Patient Age}$
• Diagnostic Target Heart Rate (THR): $\text{THR} = 0.85 \times \text{MPHR}$
• Double Product (Rate-Pressure Product): $\text{RPP} = \text{Peak Heart Rate} \times \text{Peak Systolic BP}$. A diagnostic stress test requires $\text{RPP} > 25,000\ \text{bpm} \cdot \text{mmHg}$.
• Radiopharmaceutical Injection Timing: The radiotracer (Tc-99m sestamibi/tetrofosmin) is injected as a rapid IV bolus when the patient achieves or exceeds $85\%\ \text{MPHR}$. The patient must continue exercising for an additional 1.0 to 2.0 minutes post-injection to ensure tracer extraction occurs during maximal hyperemic blood flow.
• Absolute Termination Criteria: Drop in systolic BP $>10\ \text{mmHg}$ with evidence of ischemia, ST-segment elevation $>1.0\ \text{mm}$, sustained ventricular tachycardia, central chest pain with ischemic ECG changes, severe ataxia, or patient request to stop.

Pharmacologic Stress Testing

For patients unable to perform adequate treadmill exercise (due to arthritis, peripheral vascular disease, amputation, stroke, or concurrent beta-blocker therapy), pharmacologic agents simulate stress.

1. Coronary Vasodilators (Adenosine Receptor Agonists)

Vasodilators induce direct hyperemic flow in normal coronary arteries via $\text{A}_{2\text{A}}$ adenosine receptor stimulation. Diseased vessels already at maximum baseline vasodilation cannot increase flow, causing relative regional hypoperfusion.

• Regadenoson (Lexiscan): Selective $\text{A}_{2\text{A}}$ receptor agonist. Administered as a single pre-filled IV bolus ($0.4\ \text{mg} / 5\ \text{mL}$) over 10 seconds, followed by a $5\ \text{mL}$ saline flush, with radiotracer injected 20 seconds post-flush. Rapid administration, no weight-based calculation required, minimal $\text{A}_1 / \text{A}_{2\text{B}}$ side effects.
• Adenosine (Adenoscan): Non-selective agonist ($\text{A}_1, \text{A}_{2\text{A}}, \text{A}_{2\text{B}}, \text{A}_3$). Continuous IV infusion at $140\ \mu\text{g/kg/min}$ for 6 minutes. Radiotracer injected at the 3-minute mark. Extremely short half-life ($<10\ \text{seconds}$).
• Dipyridamole (Persantine): Indirect vasodilator. Inhibits nucleoside transport, preventing cellular reuptake and degradation of endogenous adenosine. Infused at $0.56\ \text{mg/kg}$ IV over 4 minutes. Radiotracer injected 3-5 minutes post-infusion.

Absolute Contraindications for Vasodilators

• Active Asthma or Severe Reactive Airway Disease / COPD: Stimulation of $\text{A}_{2\text{B}}$ and $\text{A}_3$ receptors triggers severe bronchospasm.
• 2nd or 3rd-Degree AV Block: Without a functioning cardiac pacemaker ($\text{A}_1$ receptor activation slows AV node conduction).
• Recent Caffeine / Methylxanthine Ingestion: Caffeine, theophylline, and aminophylline are competitive antagonists at adenosine receptors. Consuming caffeine or chocolate within 12 to 24 hours prior to testing blunts vasodilation, producing false-negative non-diagnostic scans.
• Low Blood Pressure: Systolic BP $<90\ \text{mmHg}$.

Reversal Agent for Vasodilators

Aminophylline ($100-250\ \text{mg}$ slow IV over 60 seconds) is a direct competitive antagonist that rapidly reverses severe adenosine-induced bronchospasm, AV block, persistent hypotension, or chest pain.

2. Inotropic & Chronotropic Agents (Dobutamine)

Used for patients who cannot exercise AND have contraindications to vasodilators (active asthma or recent caffeine consumption).

• Mechanism: Synthetic catecholamine $\beta_1$-adrenergic receptor agonist. Increases heart rate, myocardial contractility, and systolic blood pressure, directly escalating myocardial oxygen demand.
• Protocol: Incremental IV infusion starting at $10\ \mu\text{g/kg/min}$, stepping to $20, 30,\ \text{and}\ 40\ \mu\text{g/kg/min}$ in 3-minute stages. If target heart rate is not achieved at $40\ \mu\text{g/kg/min}$, Atropine ($0.25-1.0\ \text{mg}$ IV) is added to block parasympathetic tone.
• Contraindications: Severe ventricular arrhythmias, recent acute MI ($<7\ \text{days}$), unstable angina, severe aortic stenosis, hypertrophic obstructive cardiomyopathy, uncontrolled hypertension ($>220/120\ \text{mmHg}$).
• Reversal Agent: Short-acting IV beta-blockers such as Esmolol ($0.5\ \text{mg/kg}$) or Metoprolol ($5\ \text{mg}$ IV).

Coronary Vascular Anatomy & 17-Segment Mapping

Interpreting myocardial perfusion SPECT scans requires mapping observed perfusion defects to specific coronary arterial supply territories across the standard 17-segment left ventricular model.

1. Left Anterior Descending (LAD) Artery

Course along the anterior interventricular sulcus. Gives off Diagonal ($D_1, D_2$) and Septal perforator branches.

• Perfusion Territory: Anterior wall, Anteroseptal wall, Anterior interventricular septum, and Left ventricular apex.
• Clinical Significance: High-grade proximal LAD stenoses ("widow-maker") threaten a large percentage of left ventricular mass, presenting as extensive anterior and apical stress defects.

2. Left Circumflex (LCX) Artery

Course along the left atrioventricular groove. Gives off Obtuse Marginal ($OM_1, OM_2$) branches.

• Perfusion Territory: Lateral wall, Anterolateral wall, and Inferolateral wall.

3. Right Coronary Artery (RCA)

Course along the right atrioventricular groove. Gives off Acute Marginal ($AM$) branches and, in right-dominant anatomies, the Posterior Descending Artery ($PDA$).

• Perfusion Territory: Inferior wall, Inferoseptal wall, Posterior septum, and Right Ventricle.

4. Coronary Dominance

• Right-Dominant ($85\%$ of population): $PDA$ arises from the RCA.
• Left-Dominant ($10\%$ of population): $PDA$ arises from the LCX.
• Co-Dominant ($5\%$ of population): $PDA$ branches arise from both RCA and LCX.